中東およびアフリカのデジタル治療（DTx）市場、製品およびサービスタイプ別（ハードウェア製品、ソリューション/ソフトウェア、サービス）、アプリケーション別（治療/ケア関連アプリケーション、予防アプリケーション）、購入モード別（グループ購入組織、個人）、販売チャネル別（B2B、B2C）、国別（サウジアラビア、南アフリカ、UAE、イスラエル、エジプト、その他の中東およびアフリカ）業界動向と2028年までの予測
市場分析と洞察: 中東およびアフリカのデジタル治療 (DTx) 市場
デジタル治療（DTx）市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に23.4％のCAGRで成長し、2028年までに106億3,936万米ドルに達すると分析しています。糖尿病、高血圧などの慢性疾患の罹患率の増加や政府機関による意識の高まりにより、デジタル治療市場の成長が加速するでしょう。
デジタル治療 (DTx) は、証拠に基づく遠隔評価ソフトウェアを使用して患者に直接治療介入を行い、幅広い行動、精神、身体障害に対応、管理、回避します。これらは単独で使用されるか、薬剤、デバイス、またはその他の治療法と組み合わせて使用され、患者のケアと健康状態を最適化します。治療中のデジタル治療 (DTx) の特性の 1 つは、臨床的に安全で効果的であるとテストされた治療法への遠隔アクセスの増加です。
企業が製品ラインを拡大し、利益を得るために行う技術の進歩は、デジタル治療（DTx）市場の成長の原動力の1つです。デジタル治療（DTx）アプリに関連するプライバシーの懸念は、デジタル治療（DTx）市場の成長の抑制要因となる可能性があります。企業間のコラボレーションは市場の成長を助け、デジタル治療（DTx）市場にとっての機会となります。デジタル治療（DTx）の品質は、顧客により良い治療と適切なケアを提供するために維持される必要があるため、正しく行う必要がありますが、多くの場合ニーズが満たされないため、これはデジタル治療（DTx）市場にとって課題となります。
The digital therapeutic (DTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the digital therapeutic (DTx) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East and Africa Digital Therapeutic (DTx) Market Scope and Market Size
The digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service. In 2021, solutions/software segment is expected to dominate the market since with the pandemic situation going on the safety is the prime responsibility, therefore people would tend to prefer this segment and the prevailing diseases will increase the market.
- On the basis of application, the digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications. In 2021, treatment/care-related applications segment is expected to dominate since this would provide treatment for the chronic disorders which are highly prevailing and the improved life style will tend to increase the market.
- On the basis of purchase mode, the digital therapeutic (DTx) market is segmented into group purchase organization and individual. In 2021, individual segment is expected to dominate the market since many people individually are accepting the digital healthcare platform and want to get treated without any contact and the initiatives taken by the government agencies will tend to increase the market.
- On the basis of sales channel, the digital therapeutic (DTx) market is segmented into B2B and B2C. In 2021, B2C segment is expected to dominate the market since the services are mostly preferred directly to the customers and hence increase the life style and let the market grow.
Digital Therapeutic (DTx) Market Country Level Analysis
The digital therapeutic (DTx) market is analysed and market size information is provided by the country, product and service type, application, purchase mode and sales channel as referenced above.
The countries covered in the digital therapeutic (DTx) market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt, and Rest of Middle East and Africa.
Middle East and Africa is expected to grow with the substantial growth rate in the forecast period of 2021 to 2028 as Middle East and Africa counties are major developing countries and focus on increasing usage of digital therapeutic (DTx) product and rising awareness about it. South Africa is expected to dominate in the market in the Middle East and Africa market due to increasing number of cases in diabetes.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by manufactures is Creating New Opportunities for Players in the Digital Therapeutic (DTx) Market
The digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Digital Therapeutic (DTx) Market Share Analysis
The digital therapeutic (DTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to digital therapeutic (DTx) market.
The major companies providing digital therapeutic (DTx) are Fitbit, Inc., ResMed, Omada Health, Inc., and Samsung among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the digital therapeutic (DTx) market.
For instance,
- In October 2020, TrialCard’s MANGO HEALTH announced a new interoperable technology platform and launched version 2.0 of Mango Health. This latest version includes third-party health service providers with turnkey access to Mango’s robust suite of patient support modules. The company will gain more new subscribers.
- 2019 年 5 月、CogniFit は、EEG を使用して適応学習を提供する一般的な評価を研究しました。また、各認知スキルの脳領域の刺激にも役立ちます。これにより、同社は脳トレーニングと新技術の世界的リーダーになることができました。
市場プレーヤーによるコラボレーション、製品の発売、事業拡大、賞や表彰、合弁事業、その他の戦略により、デジタル治療 (DTx) 市場における企業市場が強化され、組織がデジタル治療 (DTx) の提供内容を改善するためのメリットももたらされます。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES
5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE
5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES
5.1.5 IMPROVED QUALITY OF LIFE
5.2 RESTRAINTS
5.2.1 PATIENT INFORMATION PRIVACY POLICIES
5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS
5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES
5.3 OPPORTUNITIES
5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS
5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES
5.3.3 PARTNERSHIP BETWEEN COMPANIES
5.3.4 EXPANSION AND LAUNCH OF PRODUCTS
5.3.5 EVENTS AND EXHIBITION
5.3.6 PHYSICIAN ADOPTION
5.4 CHALLENGES
5.4.1 CLINICAL VALIDATION
5.4.2 REGULATORY APPROVAL
5.4.3 PAYER REIMBURSEMENT
6 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
6.1 IMPACT ON DEMAND
6.2 IMPACT ON SUPPLY
6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19
6.4 CONCLUSION
7 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE
7.1 OVERVIEW
7.2 SOLUTION/SOFTWARE
7.3 HARDWARE PRODUCTS
7.4 SERVICE
8 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 TREATMENT/CARE-RELATED APPLIACTIONS
8.2.1 DIABETES
8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
8.2.3 SMOKING CESSATION
8.2.4 CHRONIC RESPIRATORY DISEASES
8.2.5 MUSCULOSKELETAL DISORDER
8.2.6 CARDIOVASCULAR DISEASES
8.2.7 MEDICATION ADHERENCE
8.2.8 GASTROINTESTINAL DISORDERS
8.2.9 REHABILITATION AND PATIENT CARE
8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT
8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS
8.3 PREVENTIVE APPLICATIONS
8.3.1 PREDIABETES
8.3.2 OBESITY
8.3.3 NUTRITION
8.3.4 LIFESTYLE MANAGEMENT
8.3.5 OTHER PREVENTIVE APPLICATIONS
9 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATION
9.2.1 SOLUTIONS/ SOFTWARE
9.2.2 HARDWARE PRODUCT
9.2.3 SERVICE
9.3 INDIVIDUAL
9.3.1 SOLUTIONS/ SOFTWARE
9.3.2 HARDWARE PRODUCT
9.3.3 SERVICE
10 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL
10.1 OVERVIEW
10.2 B2B
10.2.1 PAYERS
10.2.2 EMPLOYERS
10.2.3 PHARMA COMPANIES
10.2.4 PROVIDERS
10.2.5 OTHER BUYERS
10.3 B2C
10.3.1 CAREGIVERS
10.3.2 PATIENTS
11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY
11.1 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY
11.1.1 SAUDI ARABIA
11.1.2 SOUTH AFRICA
11.1.3 UAE
11.1.4 ISRAEL
11.1.5 EGYPT
11.1.6 REST OF MIDDLE EAST & AFRICA
12 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
13 SWOT
14 COMPANY PROFILE
14.1 FITBIT,INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 LIVONGO
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 RESMED
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 OMADA HEALTH, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 GINGER
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 SAMSUNG
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 MINDSTRONG HEALTH
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 2MORROW INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 AKILI INTERACTIVE LABS, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ATENTIV
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 AYOGO HEALTH INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 BETTER THERAPEUTICS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 CANARY HEALTH
14.13.1 COMPANY SNAPSHOT
14.13.2 SOLUTION PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CLICK THERAPEUTICS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 COGNIFIT
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 COGNOA
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 GAIA AG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 HAPPIFY, INC.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 KAIA HEALTH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MANGO HEALTH
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 NATURAL CYCLES USA CORP
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 NOOM, INC.
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENT
14.23 PEAR THERAPEUTICS, INC.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 SMARTPATIENT GMBH
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 VOLUNTIS
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENTS
14.26 WELLDOC, INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 WELLTHY THERAPEUTICS PVT LTD
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
表のリスト
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))
TABLE 4 MIDDLE EAST & AFRICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 32 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 33 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 34 SAUDI ARABIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 35 SAUDI ARABIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 36 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 37 SAUDI ARABIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 38 SAUDI ARABIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 39 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 SAUDI ARABIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 SAUDI ARABIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 UAE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 UAE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 57 UAE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 58 UAE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 59 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 UAE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 UAE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 62 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 64 ISRAEL TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 ISRAEL PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 67 ISRAEL GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 68 ISRAEL INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 69 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 ISRAEL B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 ISRAEL B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 72 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 73 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 EGYPT TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 EGYPT PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 77 EGYPT GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 EGYPT B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 EGYPT B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 82 REST OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
図表一覧
LIST OF FIGURES
FIGURE 1 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.
FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
FIGURE 15 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020
FIGURE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)
FIGURE 18 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020
FIGURE 20 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020
FIGURE 24 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020
FIGURE 28 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 30 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)
FIGURE 32 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)
FIGURE 33 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)
FIGURE 36 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
